Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Breast Cancer

Free Subscription 16.09.2019 1 Am J Clin Oncol 2 Ann Oncol 2 Ann Surg Oncol 4 Anticancer Res 4 BMC Cancer 1 Breast Cancer (Dove Med Press) 2 Breast Cancer Res 5 Breast Cancer Res Treat 17 Breast J 2 Cancer Chemother Pharmacol 1 Cancer Res 1 Carcinogenesis 7 Clin Breast Cancer 2 Clin Cancer Res 1 Eur J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 5 J Natl Cancer Inst 1 J Nucl Med 1 J Surg Oncol 1 Lancet Oncol 1 N Engl J Med 1 Oncogene 2 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. KIL WJ, Lee IJ, Pham T, Cho IH, et al
   Practical Heart Sparing Breast Cancer Radiation Therapy Using Continuous Positive Airway Pressure (CPAP) in Resource-Limited Radiation Oncology Clinics.
   Am J Clin Oncol. 2019 Sep 9. doi: 10.1097/COC.0000000000000597.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. BARTLETT JMS, Sgroi DC, Treuner K, Zhang Y, et al
   Breast Cancer Index and Prediction of Benefit from Extended Endocrine Therapy in Breast Cancer Patients Treated in the Adjuvant Tamoxifen - To Offer More? (aTTom) Trial.
   Ann Oncol. 2019 Aug 28. pii: 5555808. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
3. ARNEDOS M, Gligorov J
   St Gallen international consensus guidelines in early breast cancer: Experts to prevent patients' overtreatment and breaking the bank?
   Ann Oncol. 2019 Aug 27. pii: 5555359. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Ann Surg Oncol

4. GARCIA D, Nasarre P, Bonilla IV, Hilliard E, et al
   Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.
   Ann Surg Oncol. 2019 Sep 12. pii: 10.1245/s10434-019-07800.
   PubMed     Text format     Abstract available
   
   
5. RIDNER S, Vicini F, Dietrich MS, Shah C, et al
   Response to Letter to the Editor Regarding "A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis".
   Ann Surg Oncol. 2019 Sep 12. pii: 10.1245/s10434-019-07804.
   PubMed     Text format    
   
   

   
   Anticancer Res

6. LEWIN NL, Luetragoon T, Shamoun L, Oliva D, et al
   The Influence of Adjuvant Radiotherapy and Single Nucleotide Polymorphisms on Circulating Immune Response Cell Numbers and Phenotypes of Patients With Breast Cancer.
   Anticancer Res. 2019;39:4957-4963.
   PubMed     Text format     Abstract available
   
   
7. INOUE N, Li W, Fujimoto Y, Matsushita Y, et al
   High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer.
   Anticancer Res. 2019;39:5009-5018.
   PubMed     Text format     Abstract available
   
   
8. GOMES I, Aguiar P, Miranda A, Nunes C, et al
   Overall Survival of Patients With Locoregional and Metastatic Breast Cancer: Is the Influence of Baseline Characteristics the Same?
   Anticancer Res. 2019;39:5135-5142.
   PubMed     Text format     Abstract available
   
   
9. RESTREPO DJ, Sisti A, Boczar D, Huayllani MT, et al
   Characteristics of Breast Cancer Patients Who Refuse Surgery.
   Anticancer Res. 2019;39:4941-4945.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

10. ZHANG J, Liu Y, Zang M, Zhu S, et al
    Lentivirus-mediated CDglyTK gene-modified free flaps by intra-artery perfusion show targeted therapeutic efficacy in rat model of breast cancer.
    BMC Cancer. 2019;19:921.
    PubMed     Text format     Abstract available
    
    
11. BORM KJ, Schonknecht C, Nestler A, Oechsner M, et al
    Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients.
    BMC Cancer. 2019;19:907.
    PubMed     Text format     Abstract available
    
    
12. DANIELS B, Kiely BE, Tang M, Tervonen H, et al
    Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015).
    BMC Cancer. 2019;19:909.
    PubMed     Text format     Abstract available
    
    
13. SCHMID S, Klingbiel D, Aebi S, Goldhirsch A, et al
    Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
    BMC Cancer. 2019;19:902.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

14. VELASQUEZ GARCIA HA, Gotay CC, Wilson CM, Lohrisch CA, et al
    Mammographic density parameters and breast cancer tumor characteristics among postmenopausal women.
    Breast Cancer (Dove Med Press). 2019;11:261-271.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res

15. LEITHNER D, Horvat JV, Marino MA, Bernard-Davila B, et al
    Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
    Breast Cancer Res. 2019;21:106.
    PubMed     Text format     Abstract available
    
    
16. BARROW MA, Martin ME, Coffey A, Andrews PL, et al
    A functional role for the cancer disparity-linked genes, CRYbetaB2 and CRYbetaB2P1, in the promotion of breast cancer.
    Breast Cancer Res. 2019;21:105.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

17. DE LIGT KM, Heins M, Verloop J, Ezendam NPM, et al
    The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors.
    Breast Cancer Res Treat. 2019 Sep 11. pii: 10.1007/s10549-019-05433.
    PubMed     Text format     Abstract available
    
    
18. SCARPITTA R, Zanna I, Aretini P, Gambino G, et al
    Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing.
    Breast Cancer Res Treat. 2019 Sep 11. pii: 10.1007/s10549-019-05429.
    PubMed     Text format     Abstract available
    
    
19. DU T, Liu B, Wang Z, Wan X, et al
    CpG methylation signature predicts prognosis in breast cancer.
    Breast Cancer Res Treat. 2019 Sep 13. pii: 10.1007/s10549-019-05417.
    PubMed     Text format     Abstract available
    
    
20. BRINKHAUS B, Kirschbaum B, Stockigt B, Binting S, et al
    Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study.
    Breast Cancer Res Treat. 2019 Sep 13. pii: 10.1007/s10549-019-05431.
    PubMed     Text format     Abstract available
    
    
21. CHENG AS, Leung SCY, Gao D, Burugu S, et al
    Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.
    Breast Cancer Res Treat. 2019 Sep 14. pii: 10.1007/s10549-019-05438.
    PubMed     Text format     Abstract available
    
    

    
    Breast J

22. BARCO NEBREDA I, Chabrera C, Garcia-Fernandez A, Gimenez N, et al
    Factors associated with the development of distant metastases in breast cancer patients-A regression model predicting organ relapse.
    Breast J. 2019 Sep 16. doi: 10.1111/tbj.13613.
    PubMed     Text format    
    
    
23. CHAN S, Sutradhar R, Yao Z, Chow E, et al
    Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13515.
    PubMed     Text format     Abstract available
    
    
24. MAZOUNI C, Conversano A, Laplace-Builhe C, Abbaci M, et al
    Reply-To Letter to the Editor; Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13626.
    PubMed     Text format    
    
    
25. GRANA-LOPEZ L, Herranz M, Macineira FA, Villares A, et al
    Apparent diffusion coefficient: Potential biomarker for complete response after neo-adjuvant chemotherapy in breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13589.
    PubMed     Text format    
    
    
26. KONTOS M, Kostakis ID, Constantinidou A, Parkin A, et al
    Primary endocrine treatment for breast cancer in the elderly.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13600.
    PubMed     Text format    
    
    
27. NAEEM MA, Shah TH, Zafar N, Khan M, et al
    Detection of JAK2 gene mutation in Pakistani women with triple-negative breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13609.
    PubMed     Text format    
    
    
28. CHENG ML, See MH, Sinnadurai S, Islam T, et al
    Adherence rate and the factors contribute toward the surgical adherence of breast cancer in Malaysia.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13617.
    PubMed     Text format    
    
    
29. CATTIN F, Fogacci T, Frisoni G, Semprini G, et al
    Reply to: Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13607.
    PubMed     Text format    
    
    
30. AGARWAL S, Chang DW
    Breast reconstruction in the patient with stable, metastatic breast cancer.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13596.
    PubMed     Text format    
    
    
31. FELIPE VC, Bitencourt AGV, Souza JA, de Azevedo MM, et al
    MRI features after radiofrequency ablation in breast cancer.
    Breast J. 2019 Sep 8. doi: 10.1111/tbj.13557.
    PubMed     Text format    
    
    
32. MCCORMICK B
    Changing the practice patterns of delivery of adjuvant radiation in the elderly with low-risk breast cancer: It's harder to do than you think!
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13496.
    PubMed     Text format    
    
    
33. LEE S, Jung Y, Bae Y
    Dermoglandular rotation flap with subaxillary advancement flap as an oncoplastic technique for breast cancer.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13503.
    PubMed     Text format     Abstract available
    
    
34. ABU SHAROUR L
    Psychometric evaluation of the Arabic version of the lymphedema life impact scale in breast cancer patients.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13620.
    PubMed     Text format    
    
    
35. BLACKHALL V, Bugelli M, Abbott N, Mullen R, et al
    The role of sentinel lymph node biopsy in planning adjuvant therapy for elderly women with low-risk breast cancer.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13577.
    PubMed     Text format     Abstract available
    
    
36. LIVINGSTON-ROSANOFF D, Hanlon B, Marka N, Vande Walle K, et al
    Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients.
    Breast J. 2019 Sep 12. doi: 10.1111/tbj.13625.
    PubMed     Text format     Abstract available
    
    
37. FRANCESCHINI G, Visconti G, Garganese G, Barone-Adesi L, et al
    Nipple-sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique.
    Breast J. 2019 Sep 9. doi: 10.1111/tbj.13529.
    PubMed     Text format     Abstract available
    
    
38. SHAH C
    Bioimpedance spectroscopy in the detection of breast cancer-related lymphedema: An ounce of prevention.
    Breast J. 2019 Sep 13. doi: 10.1111/tbj.13618.
    PubMed     Text format    
    
    

    
    Cancer Chemother Pharmacol

39. SAKURADA T, Bando S, Zamami Y, Takechi K, et al
    Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study.
    Cancer Chemother Pharmacol. 2019 Sep 9. pii: 10.1007/s00280-019-03948.
    PubMed     Text format     Abstract available
    
    
40. SUN Y, Yan L, Guo J, Shao J, et al
    Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
    Cancer Chemother Pharmacol. 2019 Sep 12. pii: 10.1007/s00280-019-03945.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

41. HATA T, Rajabi H, Takahashi H, Yasumizu Y, et al
    MUC1-C Activates The NuRD Complex To Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
    Cancer Res. 2019 Sep 13. pii: 0008-5472.CAN-19-1034.
    PubMed     Text format     Abstract available
    
    

    
    Carcinogenesis

42. WANG K, Tu Y, Wan JB, Chen M, et al
    Synergistic anti-breast cancer effect of pulsatilla saponin D and camptothecin through interrupting autophagic-lysosomal function and promoting p62-mediated ubiquitinated protein aggregation.
    Carcinogenesis. 2019 Aug 27. pii: 5554930. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

43. DU Q, Che J, Jiang X, Li L, et al
    PD-L1 Acts as a Promising Immune Marker to Predict the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30649.
    PubMed     Text format     Abstract available
    
    
44. ABDEL-RAHMAN O
    Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract-Level Socioeconomic Database.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30647.
    PubMed     Text format     Abstract available
    
    
45. YOON GY, Chae EY, Cha JH, Shin HJ, et al
    Imaging and Clinicopathologic Features Associated With Pathologic Complete Response in HER2-positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Dual HER2 Blockade.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30653.
    PubMed     Text format     Abstract available
    
    
46. YOO SH, Kim TY, Kim M, Lee KH, et al
    Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast Cancer.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30655.
    PubMed     Text format     Abstract available
    
    
47. JIANG Y, Liu Y, Tan X, Yu S, et al
    TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2019 Jun 13. pii: S1526-8209(18)30866.
    PubMed     Text format     Abstract available
    
    
48. PAVLOVIC R, Jankovic SM, Milovanovic JR, Stefanovic SM, et al
    The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30651.
    PubMed     Text format     Abstract available
    
    
49. GUO JY, Wang MZ, Wang MS, Sun T, et al
    The Undervalued Effects of Polychlorinated Biphenyl Exposure on Breast Cancer.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30648.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

50. HAMY AS, Bonsang-Kitzis H, De Croze D, Laas E, et al
    Interaction between molecular subtypes, stromal immune infiltration before and after treatment in breast cancer patients treated with neoadjuvant chemotherapy.
    Clin Cancer Res. 2019 Sep 12. pii: 1078-0432.CCR-18-3017.
    PubMed     Text format     Abstract available
    
    
51. HE X, Ji J, Tian M, Esteva FJ, et al
    Long-term survival analysis of adjuvant chemotherapy with or without trastuzumab in patients with T1, node-negative HER2-positive breast cancer.
    Clin Cancer Res. 2019 Sep 12. pii: 1078-0432.CCR-19-0463.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

52. TRUNTZER C, Isambert N, Arnould L, Ladoire S, et al
    Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer.
    Eur J Cancer. 2019;120:97-106.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

53. BOSMA SCJ, Hoogstraat M, van der Leij F, de Maaker M, et al
    Response to preoperative radiotherapy in relation to gene expression patterns in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2019 Sep 13. pii: S0360-3016(19)33756.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

54. KIM HA, Lee JW, Nam SJ, Park BW, et al
    Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
    J Clin Oncol. 2019 Sep 16:JCO1900126. doi: 10.1200/JCO.19.00126.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

55. SHIH YT, Shen Y
    Time to Consider a Personalized Approach to Incorporate Tomosynthesis into Routine Breast Cancer Screening.
    J Natl Cancer Inst. 2019 Sep 10. pii: 5567104. doi: 10.1093.
    PubMed     Text format    
    
    
56. FAHRMANN JF, Vykoukal J, Fleury A, Tripathi S, et al
    Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer.
    J Natl Cancer Inst. 2019 Sep 10. pii: 5567103. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
57. LOWRY KP, Trentham-Dietz A, Schechter CB, Alagoz O, et al
    Long-term Outcomes and Cost-effectiveness of Breast Cancer Screening with Digital Breast Tomosynthesis in the United States.
    J Natl Cancer Inst. 2019 Sep 10. pii: 5567105. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
58. SPERLING AS, Ebert BL
    CHIPing away at breast cancer.
    J Natl Cancer Inst. 2019 Aug 27. pii: 5555366. doi: 10.1093.
    PubMed     Text format    
    
    
59. COMEN EA, Bowman RL, Selenica P, Kleppe M, et al
    Evaluating clonal hematopoiesis in tumor infiltrating leukocytes in breast cancer and secondary hematologic malignancies.
    J Natl Cancer Inst. 2019 Aug 27. pii: 5555367. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

60. LEUNG CN, Canter BS, Rajon D, Back TA, et al
    Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with Radium-223: The Role of Bystander Effects and their Potential for Therapy.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.227835. doi: 10.2967/jnumed.119.227835.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

61. RATTI F, Serenari M, Zanello M, Prosperi E, et al
    Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases.
    J Surg Oncol. 2019 Sep 9. doi: 10.1002/jso.25702.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

62. GIULIANO M, Schettini F, Rognoni C, Milani M, et al
    Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
    Lancet Oncol. 2019 Sep 4. pii: S1470-2045(19)30420.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

63. HAYES DF
    HER2 and Breast Cancer - A Phenomenal Success Story.
    N Engl J Med. 2019 Sep 10. doi: 10.1056/NEJMcibr1909386.
    PubMed     Text format    
    
    

    
    Oncogene

64. YANG T, Ren C, Qiao P, Han X, et al
    Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Oncogene. 2019 Sep 11. pii: 10.1038/s41388-019-0982.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

65. KATSUTA E, Maawy AA, Yan L, Takabe K, et al
    High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptorpositive breast cancer.
    Oncol Rep. 2019 Aug 12. doi: 10.3892/or.2019.7275.
    PubMed     Text format     Abstract available
    
    
66. GORNOWICZ A, Szymanowski W, Bielawska A, Szymanowska A, et al
    Monoclonal antiMUC1 antibody with novel octahydropyrazino[2,1a:5,4a']diisoquinoline derivative as a potential multitargeted strategy in MCF7 breast cancer cells.
    Oncol Rep. 2019 Aug 2. doi: 10.3892/or.2019.7256.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

67. ELBASHEER MMA, Alkhidir AGA, Mohammed SMA, Abbas AAH, et al
    Spatial distribution of breast cancer in Sudan 2010-2016.
    PLoS One. 2019;14:e0211085.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: